Latest News and Press Releases

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

CDT Announces Canadian Patent for AZD5904 in Male Infertility

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

CDT Equity Inc. Announces Reverse Stock Split

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth